Investors

Swanbridge Capital

Swanbridge Capital is an early-stage venture capital fund that is focused on (pre-)seed investments in the life sciences industry. The fund invests in the development of novel therapeutics, diagnostics and medical devices. Swanbridge Capital was founded in 2016 and is based in Rotterdam, the Netherlands.

For more information: www.swanbridgecapital.nl

Van Herk Ventures

Van Herk Ventures is part of the Rotterdam-based Van Herk Groep and holds a portfolio of investments in real estate, energy and life sciences. The Van Herk Groep invests in the life sciences sector through direct investments in private and listed companies and in venture capital funds. Major investments include Galapagos, Zealand Pharma, BioInvent, DCprime, Ablynx (sold to Sanofi), and Crucell (sold to J&J).

For more information: www.vanherkgroep.nl/beleggingen

Thuja Capital

Thuja Capital Management (Thuja) manages several venture capital funds aimed at building and scaling companies in the fields of (bio)pharmaceuticals, medtech and digital health. In addition to generating a financial return for its investors, Thuja’s investments positively impact the health and well-being of patients. Thuja serves physicians and patients worldwide by providing capital to daring entrepreneurs with ground-breaking product concepts locally.

For more information: www.thujacapital.com

Erasmus MC

Erasmus MC is an international leading academic hospital. Erasmus MC staff, volunteers and students work with passion and dedication to achieve a safe, first-rate healthcare for patients with complex disorders, rare conditions or acute needs. Erasmus MC is recognized as a world-class scientific research organization.

For more information: www.erasmusmc.nl